Multiple Endocrine Neoplasia Type 1 - 9 Studies Found
Active, not recruiting |
: Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery :
|
Not yet recruiting |
: Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment : Pancreatic Neuroendocrine Tumors in MEN1 : 2016-03-02 : Drug: Somatostatin-Analog A long-acting somatostatin-analog will be applied. |
Recruiting |
: Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients : Multiple Endocrine Neoplasia : 2017-02-07 |
Recruiting |
: Genetic Evaluation of Families With Endocrine Cancers :
: 2013-02-15 : Genetic: Blood draw Blood draw |
Completed |
: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer :
|
Not yet recruiting |
: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor :
|
Recruiting |
: Familial Investigations of Childhood Cancer Predisposition :
|
Recruiting |
: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors) :
: 2017-02-02 :
|
Completed |
: Capecitabine and Temozolomide for Neuroendocrine Cancers : Neuroendocrine Tumors : 2009-03-23 :
|